Patents by Inventor Sotirios Gartaganis

Sotirios Gartaganis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARSTATIN PEPTIDES
    Publication number: 20130150298
    Abstract: The present invention relates to parstatin peptides, compositions comprising parstatin peptides and their use in the treatment of various disorders, including angiogenesis-related diseases, ocular neovascularisation and related disease states, ischemia-reperfusion injury and myocardial-related disease states, and renal disorders.
    Type: Application
    Filed: August 5, 2010
    Publication date: June 13, 2013
    Inventors: Nikos Tsopanoglou, Michael Maragoudakis, Stanley Vinores, Jennifer Strande, Sotirios Gartaganis, Dimitrios Siablis
  • Parstatin peptides and uses thereof
    Patent number: 8389476
    Abstract: The invention provides parstatin peptides, particularly a mammalian parstatin peptide including amino acids 1-26 of full length mammalian parstatin, preferably a human parstatin. The invention provides parstatin peptides in appropriate pharmaceutical carriers and formulated for administration. The invention provides for the use of the peptide for example as a medicament or for the preparation of a medicament. The invention provides methods of use for parstatin peptides including for inhibition of angiogenesis, for example for inhibition of ocular angiogenesis, for methods of cardioprotection, and for methods of prevention and treatment of myocardial ischemia-reperfusion injury.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: March 5, 2013
    Assignees: The Johns Hopkins University School of Medicine, Medical College of Wisconsin
    Inventors: Nikos E. Tsopanoglou, Michael E. Maragoudakis, Stan Vinores, Sotirios Gartaganis, Jennifer L. Strande
  • PARSTATIN PEPTIDES AND USES THEREOF
    Publication number: 20100197580
    Abstract: The invention provides parstatin peptides, particularly a mammalian parstatin peptide including amino acids 1-26 of full length mammalian parstatin, preferably a human parstatin. The invention provides parstatin peptides in appropriate pharmaceutical carriers and formulated for administration. The invention provides for the use of the peptide for example as a medicament or for the preparation of a medicament. The invention provides methods of use for parstatin peptides including for inhibition of angiogenesis, for example for inhibition of ocular angiogenesis, for methods of cardioprotection, and for methods of prevention and treatment of myocardial ischemia-reperfusion injury.
    Type: Application
    Filed: December 23, 2009
    Publication date: August 5, 2010
    Applicants: Johns Hopkins University, Medical College of Wisconsin
    Inventors: Nikos E. Tsopanoglou, Michael E. Maragoudakis, Stan Vinores, Sotirios Gartaganis, Jennifer L. Strande